Provectus Biopharmaceuticals Announces Publication of In Vitro Data from Research on Oral Delivery of PV-10® at American Society of Clinical Oncology (ASCO) 2021 Annual Meeting
June 09, 2021 07:00 ET
|
Provectus Biopharmaceuticals Inc.
— PV-10 treatment induced autophagic cell death in all breast, colorectal, head and neck, and testicular cancer cell lines tested — Represents prerequisite in vitro data for clinical testing...
Rheostat Therapeutics Announces $23 Million Series A Financing; To Develop Potential Treatments for Neurodegenerative Diseases
November 26, 2018 09:00 ET
|
Rheostat Therapeutics
CAMBRIDGE, Mass., Nov. 26, 2018 (GLOBE NEWSWIRE) -- Rheostat Therapeutics, a biotech company focused on the discovery of novel treatments for neurodegeneration, cognition and rare diseases, today...
Elsevier Updates Infectious Diseases Reference Aimed at Controlling and Preventing Neglected and Emerging Worldwide Diseases
February 27, 2017 04:00 ET
|
Elsevier, Inc.
CAMBRIDGE, MA--(Marketwired - February 27, 2017) - Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the publication of an...
Elsevier Publishes New Encyclopedia of Immunobiology
May 12, 2016 04:00 ET
|
Elsevier, Inc.
CAMBRIDGE, MA--(Marketwired - May 12, 2016) -
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the...